Albert Hallsworth

1.2k total citations
15 papers, 334 citations indexed

About

Albert Hallsworth is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Albert Hallsworth has authored 15 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Neurology and 7 papers in Cancer Research. Recurrent topics in Albert Hallsworth's work include Neuroblastoma Research and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Virus-based gene therapy research (3 papers). Albert Hallsworth is often cited by papers focused on Neuroblastoma Research and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Virus-based gene therapy research (3 papers). Albert Hallsworth collaborates with scholars based in United Kingdom, Netherlands and Ireland. Albert Hallsworth's co-authors include Louis Chesler, Yann Jamin, Simon P. Robinson, Florence I. Raynaud, Melanie Valenti, Hannah Webber, Suzanne A. Eccles, Alexis K. de Haven Brandon, Michelle D. Garrett and Kevin Petrie and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Albert Hallsworth

13 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Albert Hallsworth United Kingdom	11	215	118	96	75	38	15	334
Abigail Altabef United States	4	434 2.0×	189 1.6×	71 0.7×	76 1.0×	30 0.8×	6	558
Carrie R. Graveel United States	11	419 1.9×	201 1.7×	59 0.6×	110 1.5×	52 1.4×	21	635
Daniela Hüber Germany	8	308 1.4×	115 1.0×	23 0.2×	119 1.6×	37 1.0×	9	454
Martin Lukačišin United States	5	199 0.9×	137 1.2×	30 0.3×	61 0.8×	14 0.4×	7	320
Tristan Cardon France	13	320 1.5×	51 0.4×	27 0.3×	81 1.1×	18 0.5×	27	447
Cynthia K. Hahn United States	6	250 1.2×	53 0.4×	45 0.5×	52 0.7×	24 0.6×	11	368
Krister J. Barkovich United States	9	252 1.2×	152 1.3×	56 0.6×	53 0.7×	45 1.2×	13	440
Hayley Ellis United Kingdom	7	202 0.9×	102 0.9×	41 0.4×	110 1.5×	17 0.4×	11	391
Jens Wuerthner United States	11	108 0.5×	245 2.1×	72 0.8×	31 0.4×	17 0.4×	24	335
Erin A. Nekritz United States	6	630 2.9×	146 1.2×	293 3.1×	203 2.7×	83 2.2×	9	787

Countries citing papers authored by Albert Hallsworth

Since Specialization

Citations

This map shows the geographic impact of Albert Hallsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Hallsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Hallsworth more than expected).

Fields of papers citing papers by Albert Hallsworth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Hallsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Hallsworth. The network helps show where Albert Hallsworth may publish in the future.

Co-authorship network of co-authors of Albert Hallsworth

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Hallsworth. A scholar is included among the top collaborators of Albert Hallsworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Hallsworth. Albert Hallsworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Almeida, Gilberto S., Philippa King, Albert Hallsworth, et al.. (2025). Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imaging. Neoplasia. 65. 101170–101170.

Workman, Paul, Paul A. Clarke, Robert te Poele, et al.. (2022). Discovery and validation of biomarkers to support clinical development of NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor. European Journal of Cancer. 174. S35–S35. 4 indexed citations

Stewart, Adam, Lisa Pickard, Albert Hallsworth, et al.. (2021). Abstract 1010: A study of combinatorial growth inhibition, cell death and DNA damage repair caused by CHK1 inhibitor SRA737 and WEE1 inhibitor adavosertib in TP53 mutated cell lines. Cancer Research. 81(13_Supplement). 1010–1010.

Moore, Andrew S., Amir Faisal, Grace Wing-Yan Mak, et al.. (2020). Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736. Blood Advances. 4(7). 1478–1491. 20 indexed citations

Brandon, Alexis de Haven, Gary Box, Albert Hallsworth, et al.. (2020). Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice. Scientific Reports. 10(1). 10799–10799. 17 indexed citations

King, David S., Gilberto S. Almeida, Colin Kwok, et al.. (2020). MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma. Oncotarget. 11(23). 2141–2159. 23 indexed citations

Almeida, Gilberto S., Rafał Panek, Albert Hallsworth, et al.. (2017). Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform. British Journal of Cancer. 117(6). 791–800. 6 indexed citations

Yogev, Orli, Karen Barker, Gilberto S. Almeida, et al.. (2016). p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance. Cancer Research. 76(10). 3025–3035. 32 indexed citations

Dolman, M. Emmy M., Evon Poon, Marli E. Ebus, et al.. (2015). Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma. Clinical Cancer Research. 21(22). 5100–5109. 47 indexed citations

10.

Ahmad, Zai, Veronica Gil, Louise Howell, et al.. (2015). Molecular and In Vivo Characterization of Cancer-Propagating Cells Derived from MYCN-Dependent Medulloblastoma. PLoS ONE. 10(3). e0119834–e0119834. 16 indexed citations

11.

Jamin, Yann, Albert Hallsworth, Rani E. George, et al.. (2014). Intrinsic Susceptibility MRI Identifies Tumors with ALKF1174L Mutation in Genetically-Engineered Murine Models of High-Risk Neuroblastoma. PLoS ONE. 9(3). e92886–e92886. 13 indexed citations

12.

Walton, Mike I., Paul D. Eve, Angela Hayes, et al.. (2012). CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs. Clinical Cancer Research. 18(20). 5650–5661. 69 indexed citations

13.

Jamin, Yann, Elizabeth R. Tucker, Evon Poon, et al.. (2012). Evaluation of Clinically Translatable MR Imaging Biomarkers of Therapeutic Response in the TH-MYCNTransgenic Mouse Model of Neuroblastoma. Radiology. 266(1). 130–140. 24 indexed citations

14.

Terrile, Marta, Kenneth Bryan, Albert Hallsworth, et al.. (2011). miRNA Expression Profiling of the Murine TH-MYCN Neuroblastoma Model Reveals Similarities with Human Tumors and Identifies Novel Candidate MiRNAs. PLoS ONE. 6(12). e28356–e28356. 27 indexed citations

15.

Gowan, Sharon, Anthea Hardcastle, Albert Hallsworth, et al.. (2007). Application of Meso Scale Technology for the Measurement of Phosphoproteins in Human Tumor Xenografts. Assay and Drug Development Technologies. 5(3). 391–402. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact